Lyerly, Herbert

Recent Publications

Crosby, EJ, Gwin, W, Blackwell, K, Marcom, PK, Chang, S, Maecker, HT, Broadwater, G, Hyslop, T, Kim, S, Rogatko, A, Lubkov, V, Snyder, JC, Osada, T, Hobeika, AC, Morse, MA, Lyerly, HK, & Hartman, ZC. (2019, May). Vaccine-Induced Memory CD8+ T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational Study. Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 25 (9), 2725-2736.

Wang, X, Wang, S, Morse, MA, Jiang, N, Zhao, Y, Song, Y, Zhou, L, Huang, H, Zhou, X, Hobeika, A, Ren, J, & Lyerly, HK. (2019, May). Prospective randomized comparative study on rivaroxaban and LMWH for prophylaxis of post-apheresis thrombosis in adoptive T cell immunotherapy cancer patients. Journal of Thrombosis and Thrombolysis, 47 (4), 505-511.

Cecchini, M, Rubin, EH, Blumenthal, GM, Ayalew, K, Burris, HA, Russell-Einhorn, M, Dillon, H, Lyerly, HK, Reaman, GH, Boerner, S, & LoRusso, PM. (2019, April). Challenges with Novel Clinical Trial Designs: Master Protocols. Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 25 (7), 2049-2057.

Qiao, G, Wang, X, Zhou, L, Zhou, X, Song, Y, Wang, S, Zhao, L, Morse, MA, Hobeika, A, Song, J, Yi, X, Xia, X, Ren, J, & Lyerly, HK. (2019, March). Autologous Dendritic Cell-Cytokine Induced Killer Cell Immunotherapy Combined with S-1 Plus Cisplatin in Patients with Advanced Gastric Cancer: A Prospective Study. Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 25 (5), 1494-1504.

Wang, J, Ren, X-R, Piao, H, Zhao, S, Osada, T, Premont, RT, Mook, RA, Morse, MA, Lyerly, HK, & Chen, W. (2019, February 8). Niclosamide-induced Wnt signaling inhibition in colorectal cancer is mediated by autophagy. The Biochemical Journal, 476 (3), 535-546.

Lyerly, HK, Osada, T, & Hartman, ZC. (2019, January). Right Time and Place for IL12: Targeted Delivery Stimulates Immune Therapy. Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 25 (1), 9-11.

Mook, RA, Wang, J, Ren, X-R, Piao, H, Lyerly, HK, & Chen, W. (2019, January). Identification of novel triazole inhibitors of Wnt/β-catenin signaling based on the Niclosamide chemotype. Bioorganic & Medicinal Chemistry Letters, 29 (2), 317-321.

Lyerly, HK, Ren, J, Canetta, R, Kim, GH, Nagai, S, Yamaguchi, T, Hatogai, K, Katayama, H, Da Rocha Dias, S, McManus, D, Soltys, K, Yang, Z, Olopade, O, Goodman, N, Reaman, G, & Gross, T. (2018, December). Global Development of Anticancer Therapies for Rare Cancers, Pediatric Cancers, and Molecular Subtypes of Common Cancers. Journal of Global Oncology, 4, 1-11.

Wang, J, Mook, RA, Ren, X-R, Zhang, Q, Jing, G, Lu, M, Spasojevic, I, Lyerly, HK, Hsu, D, & Chen, W. (2018, November). Identification of DK419, a potent inhibitor of Wnt/β-catenin signaling and colorectal cancer growth. Bioorganic & Medicinal Chemistry, 26 (20), 5435-5442.

Zhao, Y, Qiao, G, Wang, X, Song, Y, Zhou, X, Jiang, N, Zhou, L, Huang, H, Zhao, J, Morse, MA, Hobeika, A, Ren, J, & Lyerly, HK. (2018, October 29). Combination of DC/CIK adoptive T cell immunotherapy with chemotherapy in advanced non-small-cell lung cancer (NSCLC) patients: a prospective patients' preference-based study (PPPS). Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico,.

View All Publications

Herbert Lyerly

Summary

Recent Publications